Navigation Links
Mylan Launches First Generic Version of Entocort EC® Capsules
Date:6/23/2011

PITTSBURGH, June 23, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that the U.S. District Court for the District of Delaware has found after trial that Mylan subsidiary Mylan Pharmaceuticals Inc. does not infringe the asserted claims of U.S. Patent No. 5,643,602 with its Abbreviated New Drug Application (ANDA) for Budesonide Capsules, 3 mg (Enteric Coated), the generic version of AstraZeneca's Entocort EC® capsules, a treatment for Crohn's disease.  

Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Budesonide Capsules, 3 mg, ANDA on May 16. This is the first generic version of this product to be introduced to the U.S. market, and Mylan Pharmaceuticals will be shipping this product immediately.

Budesonide Capsules, 3 mg, had U.S. sales of approximately $350 million for the 12 months ending March 31, 2011, according to IMS Health.

Currently, Mylan has 164 ANDAs pending FDA approval representing $94.2 billion in annual sales, according to IMS Health. Forty-five of these pending ANDAs are potential first-to-file opportunities, representing $25.8 billion in annual brand sales, for the 12 months ending Dec. 31, 2010, according to IMS Health.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com. For more information about generic drugs, please visit

SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Mylan Receives Approval for Generic Version of Aricept® Tablets
2. Mylan Receives Approval for Generic Version of Effexor XR® Capsules
3. Mylan Launches Generic Version of Roxicodone® Tablets
4. Mylan Launches Generic Version of Depakote® Sprinkle Capsules
5. Mylan Launches First Generic Version of Xibrom® Ophthalmic Solution
6. Mylan Launches First Generic Version of Amrix® Capsules
7. Mylan Launches Generic Version of Risperdal® M-Tab®
8. Mylan Launches First Generic Version of Femara® Tablets
9. Mylan Launches Generic Version of Famvir® Tablets
10. Mylan Receives Approval for Generic Version of Xalatan® Ophthalmic Solution
11. Mylan Announces Exclusive Distribution Partnership with Humeca to Expand Burn and Wound Care Portfolio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 2015  Delays in the launch and execution ... the decision-making process, resulting in missed opportunities and ... biopharmaceutical companies to develop a tactical approach to ... and more meaningful insights. According ... three-quarters of benchmarked study participants use review cycle ...
(Date:8/28/2015)... -- Research and Markets ( ... "Investigation Report on China,s Pranoprofen Market, 2010-2019" ... discovered by Welfide (Mitsubishi Tanabe Pharma Corporation formerly ... inflammatory drug, pranoprofen was later developed into eye ... trade name of pranopulin for the treatment of ...
(Date:8/28/2015)... 2015 Research and Markets ... "Investigation Report on China,s Tobramycin Market, 2010-2019" ... traditional antibiotic whose eye drop and ointment are the ... infection or inflammation caused by eye infection. Currently, dozens ... able to produce tobramycin, among which the Top 5 ...
Breaking Medicine Technology:Expediting the Pharmaceutical Market Research Process for Faster Insights 2Investigation Report on China's Pranoprofen Market, 2010-2019 2Investigation Report on China's Tobramycin Market, 2015-2019 2
... Misonix, Inc. (NASDAQ: MSON ), ... markets innovative therapeutic ultrasonic products worldwide for wound ... surgical and medical applications, today announced plans to ... results on Wednesday, November 9, 2011.  Michael A. ...
... 2011 Allied Healthcare Products, Inc. (NASDAQ: AHPI ) ... sales. Allied,s net loss for the first quarter of ... cents per basic and diluted share, versus a loss of about ... year,s first quarter. Allied,s sales for the quarter ending ...
Cached Medicine Technology:Misonix Schedules First Quarter Fiscal 2012 Financial Results Conference Call; November 9, 2011 at 4:30 p.m. Eastern 2Allied Healthcare Products Reports First Quarter Loss on Sales Decline 2Allied Healthcare Products Reports First Quarter Loss on Sales Decline 3Allied Healthcare Products Reports First Quarter Loss on Sales Decline 4
(Date:8/28/2015)... ... August 28, 2015 , ... With the goal of furthering ... the second year to the Adams County Fairgrounds in Mendon, IL on May 30th, ... money to support music education in the underfunded school districts of Mendon and its ...
(Date:8/28/2015)... ... August 28, 2015 , ... As reported by ... received FDA clearance for results that last for two years, the longest of ... for patients who are looking for a long-lasting, effective solution for their cellulite, according ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... those who might personally be struggling with chemical dependency, may be able to ... Drug Rehabilitation, a results-driven holistic treatment center for addiction located in Western Michigan. ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... Library for documenting and diagramming network and data center assets and audio-video devices, ... Device Model, Cisco Nexus 5000 Series, HP ProLiant Gen9, EMC VNX Series , ...
(Date:8/28/2015)... ... August 28, 2015 , ... The ... honoring military veterans leading in business. Mr. Troy Mizell, Chairman of the ... inaugural Nashville Business Journal's 2015 Veterans Awards will recognize Nashville military veterans who, ...
Breaking Medicine News(10 mins):Health News:Best Drug Rehabilitation Interviews Country-Rock Duo Highway Run at the 2015 "Music With A Mission" Benefit Concert 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 2Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 3Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 2Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 3Health News:MyGenetx Board Member Receives Veterans Award 2
... , The Blanket Purchase Agreement will expedite the purchasing ... , , IRVINE, Calif., June 24 ChromaDex ... reference standards and contract research, announced today that the ... (BPA) with the Company. The Agreement covers all ...
... to Lure Physicians , , IRVING, Texas, June 24 ... any other type of doctor, according to a new report ... AMN Healthcare company. , , The firm,s ... 3,200 physician recruiting assignments Merritt Hawkins conducted from April 1, ...
... to generations as the Cookie Doctor(R) behind the Dr. ... weight-conscious followers of his diet regimen , , ... of Entertainment Tonight, was on hand as renowned physician, ... and autographed copies of his new book, Dr. ...
... ... to use and helps grow back eyelashes with visible results that can be seen over ... in a clinical trial noticed they would gradually grow back eyelashes; first at 4 weeks, ... , ...
... ... CEO of HealthCare Partners Affiliates Medical Group, a Torrance, California-based cost-effective healthcare organization ... Northridge Medical Group, Inc., an independent physicians association (IPA) providing care to 24,000 ... , ...
... , Completed NDA submission could lead to marketing approval in ... Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that it ... to the U.S. Food and Drug Administration (FDA) for pixantrone ... requested priority review, which if granted could lead to an ...
Cached Medicine News:Health News:ChromaDex Establishes a Blanket Purchase Agreement With the National Institutes of Health 2Health News:Report: Primary Care Doctors in Greatest Demand 2Health News:Hundreds of Fans and Entertainment Tonight Canada Greet Dr. Siegal's COOKIE DIET(R) Creator Sanford Siegal, D.O., M.D., at Book Signing Event in Montreal, Quebec 2Health News:Hundreds of Fans and Entertainment Tonight Canada Greet Dr. Siegal's COOKIE DIET(R) Creator Sanford Siegal, D.O., M.D., at Book Signing Event in Montreal, Quebec 3Health News:Grow Back Eyelashes - Orange County Plastic Surgeon Now Helps Patients Grow Longer, Fuller Darker Eyelashes With FDA-Approved Prescription Lash Treatment, Latisse 2Health News:HealthCare Partners Medical Group and Northridge Medical Group Join Forces 2Health News:HealthCare Partners Medical Group and Northridge Medical Group Join Forces 3Health News:Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review 2Health News:Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review 3Health News:Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: